Afya Limited (AFYA)
$
15.27
+0.17 (1.11%)
Key metrics
Financial statements
Free cash flow per share
12.0892
Market cap
7.5 Billion
Price to sales ratio
2.1056
Debt to equity
0.7017
Current ratio
0.9362
Income quality
2.0163
Average inventory
0
ROE
0.1598
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Afya Limited, through its subsidiaries, operates as a prominent medical education group in Brazil, offering a diverse array of educational products and services. These include medical schools, medical residency preparatory courses, graduate courses, and various programs aimed at lifelong medical learners within its distribution network as well as to third-party medical schools. The operating expenses amount to $1,076,613,000.00 encompassing various operational costs incurred. Additionally, Afya provides digital health services through a subscription-based mobile app and website portal, which are designed to aid health professionals and students with clinical decision-making by offering tools such as medical calculators, charts, and updated content on prescriptions, clinical scores, medical procedures, and laboratory exams. The earnings per share (EPS) is reported at $7.01 indicating the company's profitability on a per-share basis. As part of its educational offerings, Afya provides health sciences courses including medicine, dentistry, nursing, and other disciplines as well as degree programs in subjects like business administration and civil engineering. The operating income ratio is 0.31 reflecting the company's operational profitability margin. As of December 31, 2021, the company operated a network of 46 undergraduate and graduate medical school campuses, consisting of 30 undergrad operating units and five approved units, with a total of 2,731 medical school seats, which included 2,481 operating seats and 278 approved seats. Founded in 1999 and headquartered in Nova Lima, Brazil, the weighted average number of diluted shares outstanding is 91,154,636.00 reflecting potential dilution effects and highlighting the company's shareholder base. The affordability of Afya’s stock at $15.44 makes it suitable for budget-conscious investors. With a market capitalization of $1,379,079,739.00 the company is classified as a small-cap player within the medical education sector. Additionally, the stock has a low average trading volume of 110,117.00 indicating lower market activity which could reflect on its liquidity. It is a key player in the Education & Training Services industry, contributing significantly to the overall market landscape, and it belongs to the Consumer Defensive sector, driving innovation and growth. The dynamic presence of Afya Limited not only enhances the educational landscape but also underscores its commitment to advancing health education in Brazil, thereby reinforcing its strategic position in the market.
Is Afya Limited (AFYA) a good investment?
Investing in Afya Limited (AFYA) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
What is Afya Limited (AFYA)'s stock forecast?
Analysts predict Afya Limited stock to fluctuate between $13.47 (low) and $19.90 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Afya Limited's market capitalization?
As of 2025-08-29, Afya Limited's market cap is $1,379,079,739, based on 90,313,015 outstanding shares.
How does Afya Limited compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Afya Limited has a Lower Market-Cap, indicating a difference in performance.
Does Afya Limited pay dividends?
Afya Limited pays dividends. The current dividend yield is 1.29%, with a payout of $0.23 per share.
How can I buy Afya Limited (AFYA) stock?
To buy Afya Limited (AFYA) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AFYA. Place an order (Market, Limit, etc.).
What is the best time to invest in Afya Limited?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Afya Limited perform in the last earnings report?
Revenue: $3,304,329,000 | EPS: $7.01 | Growth: 64.17%.
Where can I find Afya Limited's investor relations reports?
Visit https://www.afya.com.br/investor-relations for detailed financial reports.
Where can I find historical stock prices for Afya Limited?
You can explore historical data from here
What is the all-time high and low for Afya Limited stock?
All-time high: $25.07 (2021-08-05) | All-time low: $8.73 (2022-07-12).
What are the key trends affecting Afya Limited stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's medical education sector. Valuation is now more attractive after a 20%+ price drop, but risks from lower pricing power, increased competition, and new quality exams remain significant. The company is shifting capital allocation toward buybacks and dividends, signaling fewer expansion opportunities and a focus on shareholder returns.
seekingalpha.com
Afya Limited (NASDAQ:AFYA ) Q2 2025 Earnings Conference Call August 13, 2025 5:00 PM ET Company Participants Luis Andre Carpintero Blanco - Chief Financial Officer Virgilio Deloy Capobianco Gibbon - Chief Executive Officer Conference Call Participants Flavio Yoshida - BofA Securities, Research Division Lucca Generali Marquezini - Itaú Corretora de Valores S.A., Research Division Marcelo Peev dos Santos - JPMorgan Chase & Co, Research Division Mauricio I Cepeda - Morgan Stanley, Research Division Renan Prata - Citigroup Inc. Exchange Research Samuel Campos Alves - Banco BTG Pactual S.A.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2025 (second quarter 2025). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second-Quarter 2025 Highligh.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today, its Board of Directors has approved a new share repurchase program. Under the share repurchase program, Afya may repurchase up to 4,000,000 of its outstanding Class A common shares, in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning.
zacks.com
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 31, 2025.
zacks.com
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 29, 2025.
zacks.com
Investors looking for stocks in the Schools sector might want to consider either Afya (AFYA) or Grand Canyon Education (LOPE). But which of these two stocks is more attractive to value investors?
zacks.com
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
zacks.com
AFYA, ROAD and PAAS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 25, 2025.
businesswire.com
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2024 Sustainability Report. The document, which presents Afya's trajectory throughout 2024, follows the Global Reporting Initiative (GRI) standards and is aligned with the Sustainable Development Goals (SDGs). It also reports specific indicators from the Sustainability Accou.
See all news
